CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,969,432 | -31.1% | 1,183,198 | -1.4% | 0.00% | -50.0% |
| Q4 2022 | $7,212,439 | -19.3% | 1,200,073 | -21.8% | 0.00% | 0.0% |
| Q3 2022 | $8,937,000 | +131.2% | 1,535,544 | +137.1% | 0.00% | +100.0% |
| Q2 2022 | $3,866,000 | +137.0% | 647,596 | +85.5% | 0.00% | – |
| Q1 2022 | $1,631,000 | +973.0% | 349,175 | +472.0% | 0.00% | – |
| Q4 2021 | $152,000 | +46.2% | 61,047 | +46.9% | 0.00% | – |
| Q2 2021 | $104,000 | -43.8% | 41,558 | -27.8% | 0.00% | – |
| Q4 2020 | $185,000 | +781.0% | 57,586 | +338.5% | 0.00% | – |
| Q4 2019 | $21,000 | -93.6% | 13,131 | -96.5% | 0.00% | – |
| Q2 2019 | $326,000 | +3975.0% | 379,279 | +3264.8% | 0.00% | – |
| Q4 2018 | $8,000 | -77.1% | 11,272 | -30.5% | 0.00% | – |
| Q3 2018 | $35,000 | -91.5% | 16,208 | -80.4% | 0.00% | – |
| Q2 2018 | $412,000 | -75.0% | 82,738 | -80.4% | 0.00% | – |
| Q1 2018 | $1,650,000 | +2042.9% | 422,954 | +1706.6% | 0.00% | – |
| Q2 2017 | $77,000 | -64.4% | 23,412 | -54.4% | 0.00% | – |
| Q1 2017 | $216,000 | – | 51,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|